TAT-Gap19 (I130A)
TAT-Gap19 (I130A) is a cell-permeable, inactive control peptide for the Cx43 hemichannel blocker TAT-Gap19. This I130A mutant does not inhibit ATP release in C6 glioma cells and is used in vitro to validate specific Cx43 hemichannel blockade in cardiovascular and neuroinflammatory research.
Product Specifications
Field of Research
Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog